Dysregulation of GTPase-Activating Protein-Binding Protein1 in the Pathogenesis of Metabolic Dysfunction-Associated Steatotic Liver Disease

Researchers found reduced levels of GTPase-activating protein-binding protein1 in patients with metabolic dysfunction-associated steatotic liver disease and metabolic dysfunction-associated steatohepatitis, suggesting its involvement in these liver disorders.